Home >
Dr. Ginpreet Kaur

Dr. Ginpreet Kaur

Associate Professor

Specialization            : Pharmacology

E mail                         : ginpreet.kaur@nmims.edu

Phone                         : 022-42332000 (Extn- 2035)

Experience                 : 16 years and 6 months

Dr. Ginpreet Kaur has completed her M Pharm (Pharmacology) from Delhi Institute of Pharmaceutical Science and research (DIPSAR), Delhi University and PhD from SPP SPTM SVKM NMIMS University.She has executed research projects  in the area of neuropharmacology and Metabolic Syndrome 

Interest areas:

  • Screening of different synthetic and herbal medicines used for the treatment of Alzheimer’s disease
  • Exploring the effects of nutraceuticals in Metabolic Syndrome.
  • Screening of antidiabetic and Anticancer activity using cell lines.
  • Exploring the role of Phytopharmacology in zebrafish model. 


  • Publications –95 (International-76, National- 19)
  • Books-2
  • Book Chapters- 28
  • Presentations- 58 (International-34 , National- 24)
  • Government funded projects –Total-4 (2 completed,2ongoing)

Ongoing: 2

  • Principal investigator for Project entitled "Exploring the role of the Emoxypine succinate in neuroinflammation induced Alzheimer’s disease by suppressing NLRP3 inflammasome pathway” sanctioned by Science & Engineering Research Board (SERB), Dept. of Science & Technology, Govt. of India,36 months,29,01,360 Lakhs. 
  • Co-investigator for Project entitled  "Pre-clinical studies of Rajat bhasma for exploring its role in Cognitive enhancement” sanctioned by Central council of research in Unani Medicine, Ministry of AYUSH, Govt. of India,36 months, 31 lakhs 

Completed- 02

  • Principal investigator for Project entitled "Innovative approach to target Type 2 Diabetes Mellitus: CB2 agonist combined with L-Arginine” Department of Science and Technology Science & Engineering Research Board, Govt of India,36 months, 24,86,350/- 
  • Co-investigator for Project entitled "Application of Radiotracer in evaluating the therapeutic potential of Morinda genus for dementia” Department of Atomic Energy,Board of Research in Nuclear Sciences(BRNS), Govt of India,36 months, 22,81,000/- 

University funded project-01

Completed  research proposal entitled "Exploring the role of the trans-anethole in neuro-inflammation induced Alzheimer’s disease rodent model by suppressing NLRP3 inflammasome pathway sanctioned by Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS (Deemed to be University) of Rs1,00,000.

Industry projects-03

Completed Ethix Pharma funded project entitled Memory enhancing effect of test product by amyloid beta (Aβ1-42) induced cognitive impairment in aged rats of Rs 2,21,200, 2months,  March 2022.

Co-investigator for Ethix Pharma funded project entitled Efficacy Study of Test sample against H. pylori infection + PGE2  and Urease determination” of Rs2,00,000, 2months,  August 2013. 

Co-investigator for Ethix Pharma funded project entitled "In-Vivo Anti- Inflammatory Dose Response Study of Polygonum Minus (Kesum) Extract In Wistar Albino Rats”of Rs 40,000 in 2012 

Conferences/Workshops/Seminars attended- 58 

Academic activities

  • She has guided Twenty one M.Pharm students for their research projects. Five candidates are registered for PhD under her supervision. 


  1. Best Oral Presentation Award for paper entitled "Zebrafish model for Iron Induced Alzheimer's Disease” was presented at 6th Nirma Institute of Pharmacy International Conference Jointly Organized with Indian Pharmacological Society, February 17-19, 2022.
  2. Prof C.C Kartha travel award for Oral Presentation during International Conference of Cardiovascular Sciences (ICCS-2020) from February 21–23, 2020, at Delhi Pharmaceutical Sciences and Research University, Delhi .
  • SPER WF-Young teacher award during 4 th   annual International conference of Society of Pharmaceutical Education and research held on February 27th and 28th 2015 at DIT University, Dehradun.
  1. "Best Oral Presentation Award” for scientific paper entitled "Evaluation of Antihyperlipidemic potential of Lagenaria Siceraria and Trigonella Foenum graceum in rats” at the 2nd Annual Conference of Society of Pharmaceutical education and Research at Jamia Hamdard, Hamdard  University, and Delhi held on 9th March, 2013
  2. Best Faculty award from SPP School of Pharmacy and Technology Management, SVKM’S NMIMS University in Year 2012
  3. Awarded by "Dr.R.D. Kulkarni Prize”: for scientific paper entitled "α-Glucosidase inhibitory activity of curcumin and curcumin in combination with piperine and quercetin" at Fourth International Conference On "Innovations in Translating Technologies   through Clinical Pharmacology”, Organized by South Asian Chapter of American College of Clinical Pharmacology, 10th to 12th December 2010, Sahyadri Guest House, Malabar Hill, Mumbai. December, 2010
  • ‘Dr. Ashok B. Vaidya Prize’ for scientific paper entitled "Antihyperlipidemic potential of combinatorial extract of curcumin in triton – induced Hyperlipidemia in rats” at Third International Annual Conference on ‘Drug Discovery & Development – Challenges in Partnership’, Organized by South Asian Chapter of American College of Clinical Pharmacology, 2nd, 3rd & 4th October, 2009 

Professional Memberships

  • Lifetime Membership of the Indian Pharmacological Society, Indian Society of hypertension, Indian Pharmaceutical Association, APTI, International Academy of Cardiovascular Sciences.
  • Nominated as Council member of Society of Pharmaceutical education and Research (SPER) Women’s forum Council.Nominated as Topic Editor for frontier journal Phytochemical-based Nanoformulations to Tackle Drug Resistance in Cancer, Phytochemical-based Nanoformulations to Tackle Drug Resistance in Cancer, Plant-Derived Natural Products: Towards Novel Interventions for Neurodegenerative Diseases, and  COVID-19: New Variants and Host Demography.Guest Associate Editor for Pharmacology of Anti-Cancer Drugs
  • Reviewer in Pharmaceutical Biology, Journal of Ayurveda and Integrative medicine, Society of Pharmaceutical Education & Research ,Journal of Medicinal Plants Research ,Journal of Food Science (JFS) Evidence-Based Complementary and Alternative Medicine
  • Registered as Pharmacist in Delhi Pharmacy Council
  • Advisory Board Member' for Bio info Publications Journals, Editorial board member of Austin Journal of Pharmacology, "Journal of Pharmaceutical Sciences and Technology Management, , SPER Times Published by Society of Pharmaceutical Education & Research, Journal of Diabetes and Metabolic Syndrome Disorders (DMSD), Austin Journal of Pharmacology & Therapeutics & Journal of Microbial Pathophysiology and Pathogenesis. 

Recent Publications

  • Thawkar, Baban S., and Ginpreet Kaur. "Betanin mitigates scopolamine-induced cognitive impairment by restoring cholinergic function, boosting brain antioxidative status, and increasing BDNF level in the zebrafish model." Fish Physiology and Biochemistry49, no. 2 (2023): 335-349.{Impact Factor:3.04}
  • Tuli, Hardeep Singh, Ginpreet Kaur, and Mükerrem Betül Yerer. "Phytochemical-based nanoformulations to tackle drug resistance in cancer." Frontiers in Pharmacology14 (2023),1165596..{Impact Factor:5.06}
  • Sravani Karri, Sanjay Sharma, Ginpreet Kaur.Design, characterization and pharmacokinetic studies of anti-Malarial drug Artemisinin by optimized self-emulsifying nano drug delivery system (SNEDDS);Journal of Dispersion Science and Technology, (2023);1-11.{Impact Factor:2.82}
  • Kumawat, Vivek S., and Ginpreet Kaur. "Cannabinoid 2 receptor agonist and L-arginine combination attenuates diabetic cardiomyopathy in rats via NF-ĸβ inhibition." Canadian journal of physiology and pharmacology100, no. 3 (2022): 259-271.{Impact Factor:2.24}
  • Bagwe-Parab, Siddhi, and Ginpreet Kaur. "Molecular targets and therapeutic interventions for iron induced neurodegeneration." Brain research bulletin156 (2020): 1-9.{Impact Factor:3.103}
© Copyright 2023. Shri Vile Parle Kelavani Mandal (SVKM) All Rights Reserved.   Disclaimer  |  Privacy Policy